About this trial
This multicenter, prospective cohort study evaluates early cardiac dysfunction in adult survivors of childhood cancer. The hypothesis of this study is that cardiac dysfunction can be detected earlier when using speckle tracking echocardiography as novel echocardiographic technique compared to conventional echocardiography.
Eligibility criteria
Qualifiers
Registered in the ChCR
Formerly treated at the Department of Pediatric Hematology/Oncology of one of five participating centers
Treated with any chemotherapy and/or chest radiation
Survived ≥ 5 years since most recent cancer diagnosis (primary cancer, relapse(s), secondary cancer) at time of examination
Disqualifiers
Study participants will be excluded if they do not meet the above mentioned inclusion criteria or refuse to participate in the study.
Trial design
Treatments tested in this trial
- cardiac assessment
Treatment groups
Sponsors and collaborators
University of Bern
Lead sponsor
University Hospital, Basel, Switzerland
Collaborator
Insel Gruppe AG, University Hospital Bern
Collaborator
Cantonal Hospital of St. Gallen
Collaborator
Luzerner Kantonsspital
Collaborator
University Hospital, Geneva
Collaborator
University Children's Hospital Basel
Collaborator